Sort by:

select Language:



UN Zika Response Multi-Partner Trust Fund (Zika Response MPTF)

United Nations UN, (2016)


To generate and manage resources towards this goal, the UN Secretary-General in collaboration with UN Agencies, Funds and Programmes (UN AFP) has launched the UN Zika Response Multi-Partner Trust Fund (Zika Response MPTF). The aim of this inter-agency pooled funding mechanism is to rapidly resource the UN system responses to Zika virus, in accordance with the overview of needs and requirements and the Zika Response Framework.
http://mptf.undp.org/factsheet/fund/ZKA00


Surveillance for Zika virus infection, microcephaly and Guillain-Barré syndrome. Interim guidance

World Health Organization, (2016)


This document provides interim recommendations for the surveillance of Zika virus infection, microcephaly and Guillain-Barré syndrome, in four different contexts and describes reporting requirements to WHO. Transmission refers to vector-borne transmission, unless specified differently. Autochthonous infection is considered to be an infection acquired in-country, i.e. among patients with no history of travel during the incubation period or who have travelled exclusively to non-affected areas during the incubation period. This document does not provide guidance on laboratory investigation or vector surveillance.
http://apps.who.int/iris/bitstream/10665/204897/1/...


Travel health advice on Zika virus

World Health Organization, (2016)


For national authorities and health care practitioners
http://who.int/ith/updates/2016_04_11/en/


Zika virus disease epidemic: Preparedness planning guide for diseases transmitted by Aedes aegypti and Aedes albopictus

European Centre for Disease Prevention and Control, (2016)


The threat posed by Zika virus infection highlights the need to reinforce preparedness arrangements for mosquito-borne diseases in EU/EEA countries, especially for pathogens transmitted by Aedes aegypti and Aedes albopictus. The aim of this document is to highlight measures that can effectively reduce the risk of importation and local transmission of pathogens transmitted by Ae. aegypti and Ae. albopictus. The main diseases of concern in this context are Zika, dengue, chikungunya and yellow fever.
http://ecdc.europa.eu/en/publications/_layouts/for...


Interim guidance for healthcare providers and Zika virus laboratory diagnosis

European Centre for Disease Prevention and Control, (2016)


This document aims to present an algorithm for deciding whom to test and provide guidance on the laboratory tests for Zika virus infection diagnosis in order to support clinical diagnostic and case reporting through surveillance among EU Member States. The algorithm is not intended for clinical management of patients with suspected Zika virus infection. The information is provisional and subject to revision when new information becomes available.
http://ecdc.europa.eu/en/publications/Publications...


Case definition

European Centre for Disease Prevention and Control, (2016)


ECDC proposed case definition for surveillance of Zika virus infection
http://ecdc.europa.eu/en/healthtopics/zika_virus_i...


Preguntas frecuentes sobre el control de vectores del virus del Zika

Pan American Health Organization PAHO; World Health Organization, Regional Office for the Americas, (2016)



http://www.paho.org/hq/index.php?option=com_conten...


70 hits